DefenCath® (taurolidine and heparin) catheter lock solution is indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis (HD) through a central venous catheter (CVC). This drug is indicated for use in a limited and specific population of patients.


August 9, 2016

Please review the current openings below and select the appropriate link to learn more about the opportunity.

Thank you for your interest in career opportunities with CorMedix. If CorMedix doesn’t currently list an open position for the job you are interested in, please check back regularly to explore our new opportunities. If you have additional questions, you may email

CorMedix Inc. is an Equal Opportunity Employer.